Gene · 9547
Papers2,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparison Bioinformatic Analysis of Extracellular Vesicles-Related Genes and MicroRNAs in Breast Cancer. | Int J Mol Sci | 2025 | 40565366 | PubTator, text mining | PubMed |
| Optimizing bone marrow harvesting sites for enhanced mesenchymal stem cell yield and efficacy in knee osteoarthritis treatment. | World J Methodol | 2025 | 40548220 | PubTator, text mining | PubMed |
| Transcriptomic profiling of vitiligo patients shows polar immune dysregulation in involved and uninvolved skin. | J Allergy Clin Immunol | 2025 | 40513622 | PubTator, text mining | PubMed |
| Identification and Mapping of Human Lymph Node Stromal Cell Subsets by Combining Single-Cell RNA Sequencing with Spatial Transcriptomics. | Eur J Immunol | 2025 | 40498289 | PubTator, text mining | PubMed |
| Potential diagnostic marker gene set for non-alcoholic steatohepatitis associated hepatocellular carcinoma with lymphocyte infiltration. | Transl Cancer Res | 2025 | 40386252 | PubTator, text mining | PubMed |
| Histone modifications and metabolic reprogramming in tumor-associated macrophages: a potential target of tumor immunotherapy. | Front Immunol | 2025 | 40375990 | PubTator, text mining | PubMed |
| The tumor microenvironment of metastatic osteosarcoma in the human and canine lung. | Commun Biol | 2025 | 40374715 | PubTator, text mining | PubMed |
| Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements. | J Transl Med | 2025 | 40369674 | PubTator, text mining | PubMed |
| Hypoxia-induced RHCG as a key regulator in psoriasis and its modulation by secukinumab. | APL Bioeng | 2025 | 40351602 | PubTator, text mining | PubMed |
| Exploring the Latent Information in Spatial Transcriptomics Data via Multi-View Graph Convolutional Network Based on Implicit Contrastive Learning. | Adv Sci (Weinh) | 2025 | 40304359 | PubTator, text mining | PubMed |
| NAT10 mediated polycystic ovary syndrome through the ac4C modification of CXCL14. | J Steroid Biochem Mol Biol | 2025 | 40300667 | PubTator, text mining | PubMed |
| E2F expression profiling-based subtypes in head and neck squamous cell carcinoma: clinical relevance, prognostic implications, and personalized therapy. | World J Surg Oncol | 2025 | 40275315 | PubTator, text mining | PubMed |
| Urine-derived stem cells from patients alleviate lupus nephritis via regulating macrophage polarization in a CXCL14-dependent manner. | Life Sci | 2025 | 40204070 | PubTator, text mining | PubMed |
| The single-cell transcriptional landscape of lung cells from PCV2d-infected mice. | Front Microbiol | 2025 | 40196036 | PubTator, text mining | PubMed |
| Transitional CXCL14+ cancer-associated fibroblasts enhance tumour metastasis and confer resistance to EGFR-TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma. | Clin Transl Med | 2025 | 40162549 | PubTator, text mining | PubMed |
| Inflammatory profiling and immune cell infiltration in dysthyroid optic neuropathy: insights from bulk RNA sequencing. | Front Immunol | 2025 | 40160813 | PubTator, text mining | PubMed |
| Fast detection of unique genomic regions. | Comput Struct Biotechnol J | 2025 | 40115535 | PubTator, text mining | PubMed |
| Wild-Type TP53 Predicts Poor Prognosis in Lower-Grade Glioma via TP53-CXCL14-GATA3 Axis. | J Mol Neurosci | 2025 | 40102292 | PubTator, text mining | PubMed |
| CXCL14 regulates ovarian endometriosis progression by targeting PCNA. | Am J Transl Res | 2025 | 40092086 | PubTator, text mining | PubMed |
| The role and mechanism study of Cxcl14 in chronic critically ill cardiac dysfunction. | Biochem Biophys Res Commun | 2025 | 40010139 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9547/papers?page=7